Bristol-Myers Squibb - Company & Market Research Reports

Home /
Companies /
Bristol-Myers Squibb

Bristol-Myers Squibb is a pharmaceutical company that develops products for various diseases, such as oncology, virology, cardiovascular diseases, serious mental illness, and immunoscience. The company has delivered 12 new medicines to patients in the past 7 years. It also provides products for Alzheimer's disease, atherosclerosis/thrombosis, hepatitis, HIV/AIDS, solid organ transplant rejection, and a wide variety of other diseases and disorders. Bristol-Myers Squibb was founded in 1990 and is based in Uxbridge, United Kingdom.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 465
Immune Disorders Drugs 196
Cardiovascular Drugs 154
Biopharmaceuticals 132
Infectious Diseases Drugs 121
Central Nervous System Drugs 104
Endocrine and Metabolic Disorders Drugs 103
Drug Discovery 102
Musculoskeletal Disorders Drugs 94
Clinical Trials 90
Pharmaceuticals 88
Leukemia Drugs 83
Hematological Drugs 83
Liver and Kidney Disorders Drugs 74
Lymphoma Drugs 64
Dermatological Drugs 59
Diabetes Drugs 54
Skin Cancer Drugs 50
Brain Cancer Drugs 47
Mental Disorders Drugs 41
Lung Cancer Drugs 40
Respiratory Drugs 38
Immunosuppressive Drugs 36
Gastrointestinal Drugs 34
Drug Delivery 32
Pharmaceutical Intermediates 30
Liver Cancer Drugs 30
Infusions and Injectables 30
Pharmaceutical Manufacturing 27
Analgesics 26
Bladder Cancer Drugs 25
Drugs by Therapeutic Area 23
Antibiotics 23
Kidney Cancer Drugs 22
HIV/AIDS Drugs 22
Breast Cancer Drugs 18
Ovarian Cancer Drugs 17
Colon Cancer Drugs 17
Cervical Cancer Drugs 17
Pancreatic Cancer Drugs 17
Psoriasis Drugs 17
Prostate Cancer Drugs 16
Urological Disorders Drugs 16
Schizophrenia Drugs 15
Thyroid Cancer Drugs 14
Sexual and Reproductive Health Drugs 14
Cancer Vaccines 13
Over the Counter (OTC) Drugs 12
Biosimilars and Biosuperiors 10
Optical Disorders Drugs 8
Generic Drugs 8
Uterine Cancer Drugs 8
Alzheimer's Disease Drugs 8
Transdermal and Transmucosal Drug Delivery 7
Vaccines 7
Cough and Cold Drugs 6
Anti-Obesity Drugs 6
Anxiety Drugs 6
Company Reports 5
Pharmacoeconomics 3
Vitamins and Dietary Supplements 3
Addiction Disorders Drugs 2
Animal Pharmaceuticals 2
Asthma Drugs 2
Inhalers and Nebulisers 1
Anesthetic Drugs 1
Allergy Drugs 1
Bronchitis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



284 reviews

2,388 Results (Page 31 of 120)
- Relevance
  Sort by

Neuropathic Pain Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4017EUR$4,490USD£3,436GBP

Rheumatoid Arthritis Market (2021 Edition) - Analysis By Drug Type (NSAIDs, DMARDs, Corticosteroids, Others), Treatment, Diagnosis, By Region, By Country: Market Insights and Forecast with Impact of COVID-19 (2021-2026)

 Report
November 2021
220 Pages
Global

From

€2147EUR$2,400USD£1,836GBP

Bispecific Antibodies Market - Global Forecast 2026-2032

 Report
January 2026
183 Pages
Global

From

€3172EUR$3,545USD£2,713GBP

€3524EUR$3,939USD£3,014GBP

Natural Killer Cell Therapeutics Market - Global Forecast 2026-2032

 Report
January 2026
187 Pages
Global

From

€3172EUR$3,545USD£2,713GBP

€3524EUR$3,939USD£3,014GBP

Direct-acting Antiviral Drug Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031F

 Report
May 2026
180 Pages
Global

From

€4026EUR$4,500USD£3,443GBP

NEED HELP FINDING THE RIGHT PRODUCT? Brian will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Pseudomonas Aeruginosa Infection Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031F

 Report
May 2026
188 Pages
Global

From

€4026EUR$4,500USD£3,443GBP

Systemic Lupus Erythematosus - Pipeline Insight, 2025

 Clinical Trials
April 2025
240 Pages
Global

From

€2684EUR$3,000USD£2,295GBP

Psoriatic Arthritis - Pipeline Insight, 2025

 Clinical Trials
April 2025
80 Pages
Global

From

€1790EUR$2,000USD£1,530GBP

Active Pharmaceutical Ingredient (API) Market - Analysis By Drug Type (Generic, Innovative), Synthesis (Synthetic, Biotech), By Application, By Region, By Country (2021 Edition): Market Insights and Forecast with Impact of COVID-19 (2021-2026)

 Report
December 2021
230 Pages
Global

From

€2147EUR$2,400USD£1,836GBP

Nonalcoholic Steatohepatitis (NASH) Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2023 to 2031

 Report
May 2023
119 Pages
Global

From

€4026EUR$4,500USD£3,443GBP

Kidney Cancer Treatment Drug Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

 Report
May 2023
98 Pages
Global

From

€3500EUR$4,190USD£3,098GBP

Global Markets and Manufacturing Technologies for Protein Drugs 2021-2026

 Report
August 2021
159 Pages
Global

From

€4921EUR$5,500USD£4,208GBP

Oral Anti-HBV Drugs Market - Global Forecast 2025-2030

 Report
August 2025
182 Pages
Global

From

€3172EUR$3,545USD£2,713GBP

€3524EUR$3,939USD£3,014GBP

Antivirals Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4017EUR$4,490USD£3,436GBP

Merkel Cell Carcinoma Disease Treatment Market - Forecast 2021 to 2026

 Report
January 2022
119 Pages
Global

From

€3982EUR$4,450USD£3,405GBP

Pseudomonas Aeruginosa Infection Treatment Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4017EUR$4,490USD£3,436GBP

Turkey Pharmaceuticals Market, By Region, Competition, Forecast & Opportunities, 2020-2030F

 Report
May 2025
85 Pages
Turkey

From

€3132EUR$3,500USD£2,678GBP

Hydroxyurea Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

 Report
October 2023
74 Pages
Global

From

€3500EUR$4,190USD£3,098GBP

Antiviral Combination Therapy Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4017EUR$4,490USD£3,436GBP

Herpangina Treatment Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4017EUR$4,490USD£3,436GBP

2,388 Results (Page 31 of 120)
- 1
- 29
- 30
- 31
- 32
- 33

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.